The Evolution Of Digital Twins – SemiEngineering

Digital twins are starting to make inroads earlier in the chip design flow, allowing design teams to develop more effective models. But they also are adding new challenges in maintaining those models throughout a chips lifecycle.

Until a couple of years ago, few people in the semiconductor industry had even heard the term digital twin. Then, suddenly, it was everywhere, causing confusion because it appeared to be nothing more than development models. Some degree of clarity finally is emerging, but not about how it will affect the development process. What may change are new customers for those models and new ways in which value can be extracted from them, and over time that may influence the models created.

To start, the term digital twin is very broad. Digital twins allow mimicking of real things through simulation, says Aki Fujimura, CEO of D2S. Flight simulators are digital twins. Driving simulators are digital twins, especially if you want to model different ways in which a car can crash, or a pilot needs to learn to control the plane under severe duress. It is a good idea to be dangerous only in a simulated context.

The term has been defined by a number of people. A digital twin is a virtual representation of a physical system that is used to answer questions that cannot be answered, or are difficult to answer, by a physical system, says Marc Serughetti, senior director in the verification group at Synopsys.

But looking at it with too large a context can be problematic. Digital twins are a great idea, but not a reality yet at least not to the extent of seamlessly covering all abstraction layers of a complex system, says Rob van Blommestein, head of marketing for OneSpin Solutions. One of the big issues is interoperability. Right now, there are a few big players that are trying to develop proprietary platforms for modeling a digital twin of a car, for example. In principle, that is great. It would allow manufacturers to have a complete virtual view of the car, including electronic, electrical, mechanical, and physical aspects. The problem is that monolithic platforms are weak by construction.

What has started to become clear are the types of digital twin that exist, and the roles they can perform. There are three elements of digital twins, says Frank Schirrmeister, senior group director for solutions marketing at Cadence. One: Digital twins for the development purpose. These are the ones that naturally fall out of the semiconductor flow. It includes things like a virtual platform, which is a digital twin for software development. Two: Digital twins related to the data. If you look at healthcare, they digital twin the hospital to optimize the process. They digital twin the person. The third element is data over time, and this is often connected to maintenance issues. So in the health domain, people look at your digital twin being your chart.

Schirrmeister uses a bathtub curve, as shown in figure 1, to show how this fits into the semiconductor world.

The digital twin for predictive maintenance has nothing to do with the digital twin used for development, continues Schirrmeister. This is a model nightmare like you wouldnt believe. In order for this to be effective, you actually need to have models of your thing in real life, and you need to maintain these models, over time. So three digital twins for development, for predictive maintenance, and then the operational and production aspect which is, how to optimize your product production line.

This ends the notion that models stop being useful at tape-out.

An emerging standard, Portable Stimulus, could become an important part of this. If high-fidelity and high-accuracy models are used for the individual components of the system, such as a sensor or applications processor, digital twins can help reduce development time by enabling realistic scenario simulation and, crucially, validation, says Chet Babla, vice president for Arms Automotive & IoT Line of Business. This can lead to better products in a shorter period of time.

Others agree. A digital twin can be better than a physical system in that they make it possible to quickly change parameters, operating conditions, functions and overall make the product more configurable instead of having to rebuild a physical system every time, says Syed Alam, global semiconductor lead at Accenture. The semiconductor industry is moving toward more configurable systems, and digital twins are a great way to design, test and manufacture them faster and cheaper.

The boundaries between stages is blurring. Suppose we tape out a design and target a new production facility, says Fram Akiki, vice president of electronics industry strategy at Siemens PLM Software. The production people may come back and say that based on the design you are using a lot of high-performance transistors, you have added a couple of layers of metal, etc. They may conclude that they need to spend another $30 million or $40 million of capital to make sure they optimize the production line for this design (see figure 2). If they dont spend the money and it turns out to be a bottleneck, you are dead. If you do spend the money and later realize that you didnt need it, you also will be in trouble because of the unnecessary expenditure. This has become even more important today. You want to optimize your manufacturing line early on. It doesnt matter if you are operating under an IDM format or if you are a fabless company because costs are costs and risks are risks, and someone has to account for them.

The digital twin is a means to an end. The first question that really needs to be addressed is, What questions are you trying to answer?' says Synopsys Serughetti. Why do I build the digital twin?

Production twinsIn semiconductor manufacturing, the concept of digital twins is finding several applications. We do wafer plane analysis (WPA) from a mask SEM picture to project what that mask will expose on wafer resist by doing a lithography simulation on the extracted contour of a SEM picture, says D2S Fujimura. That is a digital twin of the wafer lithography machine.

This concept can be taken further than would be possible when restricted to real data only. One might want to have a deep learning network that can learn how to classify different types of defects, says Fujimura. But semiconductor fabs and mask shops are very good at avoiding defects. So it is difficult to collect the millions of specific example pictures of each type of a defect in order to properly train the network. Digital twins that generate pictures that look like SEM images, or inspection images out of CAD data, enable a programmer to generate any number of any kind of defect image at will without finding a way to manufacture one to take a picture of.

Even after devices have been deployed in the field, models remain useful. Post-silicon is a different scope of digital twin, but thats one that may become more important as we move forward and as systems become more complex, says Serughetti. In the semiconductor world we tend to think of hardware and software. But the reality is, they live in an environment. And if you are starting to think about digital twins in that space, you need to be able to model the hardware, the software and the environment that has an influence on that hardware and software.

Knowing how your chips are being used is important. Live data from physical chips, either being manufactured, assembled and tested in silicon form, on system/board or in end deployment, are all being collected and integrated with the Digital Thread data, says Accentures Alam. This enables design and product engineers access to the next level of analysis, which helps them improve their designs as well as provide data into the semiconductor ecosystem to resolve design and performance issues.

And being able to predict their performance when used in new situations adds value. Digital twins enable the possibility to test multiple deployment scenarios, including challenging corner cases, with a highly automated and consistent approach, but without the limitation of needing access to physical systems, says Arms Babla. This ability to configure, test, analyze, adjust, configure, and test enables a powerful feedback mechanism to optimize system specifications and finalize or enhance designs.

But some of the necessary models remain elusive. In order to cope with actual field data, real-time execution is often a requirement for digital twins, says Roland Jancke, head of department for design methodology at Fraunhofer IIS Engineering of Adaptive Systems Division. The main advantage of a digital twin as opposed to conventional system-level models is its existence over the complete system lifecycle. This helps during the development and verification phase, but improves itself later by using field data, thereby keeping an eye on safe operation as well as expected responses.

Over time, those models will reinforce themselves. Being able to mine data from the digital twin will provide design engineers the next level of confidence in the simulation models they are building, says Alam. The ability to analyze different test results as well as power consumption and performance parameters means that there will be less re-spins of a product. The design engineers can produce better configurations and derivatives of devices faster and at a lower cost.

Digital twins shift leftModels within the development flow are changing. We are seeing a shift left, and a lot of things that in the past were done in series, such as the development of hardware and do the software later when the hardware has matured, are now being done simultaneously, says Siemens Akiki. To do this effectively is dependent on having effective digital models.

The development of virtual prototypes has been happening for some time. In addition, accuracy can be traded with speed of modeling by deploying models of varying abstraction levels, says Babla. For example, a simple programmers view model of components may suffice for base functionality checking and initial software development, whereas a detailed physics-based image sensor model combined with a full processor RTL model will allow high-accuracy modeling of vehicle or industrial robot dynamics under real-life environmental conditions, such as humidity, temperature or even road surface conditions.

And those models are being connected into flows. Virtual prototyping can start early, before RTL is available, says Serughetti. Then you go into hybrid, for example, with the virtual prototyping and emulation. And then you can go to prototyping, which is FPGA-based, which can also be hybrid. Now you may be talking more system validation, where you connect to the rest of the system. So there is definitively a flow where all those technologies play a role along the development chain. I dont think they are exclusive of each other. And they are not like one finishes, and the next one starts.

Portable Stimulus can help keep those models in sync. Not all tests will run on each level of accuracy, says Cadences Schirrmeister. Some tests may require you to have enough implementation detail to actually work, where others, which are more abstract elements, will work across all fidelities. Some may require the bare metal drivers to be available. If you run the same test on a more abstract implementation of it, then you dont run the real drivers. But you still can run the test itself.

Getting the right abstractions can be tricky. Models used for a digital twin should run as fast as possible while being as accurate as necessary, says Fraunhofers Jancke. The abstraction needs to be representing interactions in the system that are in question, while neglecting what seem to be unnecessary details for the investigation at hand.

The uptake in virtual prototypes is leading to design gains. Customers are being more proactive in the specification phase, says Serughetti. They are benefiting from that because the value of moving to a virtual environment is providing more clarity between hardware and software. There has been a very strong benefit on that side, and the shift left has happened because now you can deploy those verification and validation technologies much more efficiently.

One problem is that digital twins tend to be proprietary. What the industry needs is an open-source, or at least interoperable, platform where open-source and commercial tools, including EDA tools, can be plugged-in seamlessly, says OneSpins van Blommestein. This is an obvious need for safety, where having independent tools checking each other is a requirement. But its not only about safety. It is also important to make sure OEMs and their supply chain have access to the best, most competitive solutions for each specific design and verification task.

Another challenge is the cost of maintaining models over time. Is the investment you have to put into that digital twin manageable for the return youre trying to get out of it, asks Serughetti. When you are at the beginning of the project and theres no physical system, it has a huge value because you can start earlier, and you get more information. Once you are later in the project, the question becomes, Whats my modeling effort for that digital twin? And what is the return for it? If the effort is too high, then people are not going to maintain it. If you are talking about a project that has a very short timeframe, the modeling effort may be too high in order to get returned value.

Digital twins created within the semiconductor flow remain primarily for internal consumption. Digital twins rely on the creation of a flow where these things happen naturally, says Schirrmeister. They are a natural byproduct of developing something. We are not really there yet, even from RTL down. There are times when you need to take into account not only the functional and timing accuracy, but also thermal effects, electromagnetic effects, power effects and all that. We have not figured that out, and its highly dependent on which question you want to answer.

The industry long has held the desire to have an executable specification from which implementations can be derived, and this would create the ultimate digital twin. What if my digital twin was my specification, asks Serughetti. If I start modifying it, I start by modifying the specification, and from that I derive the implementation. Unfortunately, I havent seen it as something that has been practical to realize so far.

ConclusionThe industry is getting more clarity on digital twins, both within the semiconductor development flow and during production and deployment. As the perceived values of doing that increase, additional time and effort will be put into the creation of the appropriate models and the means to keep them in sync. Ultimately, a digital twin has value if it provides a better way to get an answer. The better way could be because its earlier, its cheaper, or it has less risk.

In this time of COVID where more people are working remotely, digital twins may offer additional value because they may be accessible anywhere and at any time.

See original here:

The Evolution Of Digital Twins - SemiEngineering

Remote Possibilities: The evolution of the home office – Pacific Northwest Inlander

click to enlarge

Photo courtesy of Design for the PPL

Design for the PPL's Erin Haskell Gourde redesigned this standard-issue home office for a client who wanted a dramatic Old World feel.

Home sweet home. It's what you've invested a lot of time and energy into, where the family gathers for meals, where you curl up in your favorite chair to relax after work. Only now, for more of us than ever before, the workday might have occurred just down the hall, at a desk nudged into a bedroom, or at a chair near a plugin in the corner of a quiet room.

But even before recent statewide closures and slowdowns forced people out of the office and into telecommuting, there was a trend toward working remotely. According to FlexJobs and Global Workplace Analytics, over the past ten years, the "remote workforce" has grown by more than 90 percent.

Photo courtesy of Design for the PPL

Designer Erin Haskell Gourde (right) enjoys a laugh with Eileen Barbieri, in her newly designed home office.

Global Workplace Analytics further estimates that more than half of the non-self-employed workforce around 75 million Americans could work from home at least part time and that the longer they work from home, the more likely it is that they will never fully return to the conventional office environment.

So how can home offices evolve to meet the needs of a new cadre of stay-at-home workers? Local designers offer ideas on how to create a multipurpose office space that not only meets workday needs, but also offers space for other activities as well.

In their Spokane real estate business, the Fowler Group's Danielle and Ryan Fowler have noticed an uptick in clients looking for extra spaces they might convert into home offices. Many transplants, says Danielle, are moving to the Spokane region knowing they'll be telecommuting.

The Fowlers include themselves in the telecommuting workforce, and like many families, they also needed space where their four children could do schoolwork. So when it came time to build, they incorporated an office into the plan for their still-under-construction Peone Prairie home.

They added steel and glass barndoor-style walls to transform the formal dining room into a roughly 12-by-12-foot, multifunctional office just off the kitchen. The glass lets light in, allows for two-way visibility, and yet provides a minimal sound barrier.

Photo courtesy of Design for the PPL

With expansive windows providing views to the stables, this office for a professional equestrian team owner incorporates built-ins to hide office-related equipment, freeing up shelf space for more interesting displays.

Another consideration in the design, says Danielle, was centralizing paperwork and other frequently-accessed office items, yet hiding clutter through built-in storage.

DESK PICK: Add a little whimsy with this petite, but perfectly functional desk. Signature Design Mirimyn Trestle Desk, Runge Furniture in Coeur d'Alene

"I wanted it to be attractive as well," Danielle says.

Aesthetics and multifunctionality are high priorities for clients, say several local interior designers who, like the Fowlers are seeing increased interest in adding a new office space or converting existing spaces into ones that accommodate those working from home.

"I would say there is a lot more awareness of how an office is designed within a home and clients to a degree have been very involved in this desire for dual function and creating beautiful rooms that they are inclined to want to spend time in that are more fluid and connected with the rest of their homes," says Tammie Ladd, of Tammie Ladd Interior Design.

In addition to more decorative lighting and design that incorporates personal touches, requests have included maximizing space, from storage units to built-ins to the room itself, Ladd says. For example, she recently completed a dual-functioning yoga studio and office space for a client and created a double workspace for another.

"We've added console tables, desks behind sofas in living rooms that can also double as a docking station or place to set up shop and still maintain the enjoyment of one of the best rooms of the home," Ladd says. "Even in a more traditional styled office with a desk, seating, task chair and built-ins, often media will also be incorporated along with direct visual connections to the main living spaces."

Photo courtesy of Design for the PPL

A desk area can be seamlessly combined with comfortable seating and media, allowing the room to offer multiple uses.

Designology's Deanna Goguen and Milieu Design's Sarah McGovern collaborated to overhaul a space for a professional equestrian team owner that also addressed the dual need of multifunctionality and livability.

DESK PICK: Ample storage in this compact, cottage-styled package. Libby Allyson Park L-Shaped DeskWalker's Furniture

Taking a design cue from the world of dressage tack, the design features a leatherwork surface and a metal and glass wall to partially enclose the space, which also has a view towards the barn and track so the owner can oversee the horses and team workout areas.

"Built-in shelves showcase awards and original art, while the enclosed cabinets below hide the day-to-day necessities like files and the printer, so that the beautiful parts can take center stage," McGovern says.

Location of the office within the home is also important. When it's closer to the front door, for example, that allows for meetings with clients without exposing the more intimate spaces of the home.

In the past, Ladd says, the kitchen was the catch-all, sometimes featuring a little desk tucked in among the cabinets that doubled as an office. Now the kitchen island might get extra outlets and charging ports, functioning more like a docking station with thoughtfully concealed or even portable storage.

Photo courtesy of Tammie Ladd Design

Tucked into a long hallway, this docking area offers the perfect location for working, while still enjoying the larger spaces of the home.

Design for the PPL's Erin Haskell Gourde says sometimes clients don't know what they want other than what they have isn't working anymore, especially as more people are finding themselves unexpectedly out of their regular office environment and working remotely from home.

DESK PICK: Tuck work away in time for happy hour with this sustainably sourced, solid walnut laptop desk Copeland Laptop Desk, Tin Roof Furniture

At the same time, she notes people may not want to devote space in their homes exclusively to work. "Don't just design it as an office and that's it, because things can change," she counsels. For example, "A library can be stunningly beautiful and then you can have, you know, cocktails in there." Recently she worked with a client to create a dramatic room, featuring office accouterments like a standalone desk and guest chairs, yet also incorporating stylish touches including a range of inset and ceiling lighting and built-in bookshelves, creating an Old World feel. It was the perfect fit for a client who wanted, "A classic beautifulplace where she can do her work, but also just want to dwell in, a place where she can just be."

Space Specs

Working from home might seem comfy and cozy, but we still need to take our bodies into account when we go about creating a home workspace. "That means practicing self-care," says Contract Design Associate's Gwen Marlow. "An office that's functional makes us feel good."

Whether it's a spot on the couch with your laptop or a wraparound desk in your former third bedroom, ergonomics are important.

"We just have to remember: Don't conform your body to your space," Marlow says.

Instead, conform your space to support your body. Check your posture aim for sitting straight up, with your shoulders relaxed and your feet on the floor. Try using pillows to alleviate pressure and offer support while seated.

If your work from home requires considerable time sitting at a desk, ergonomic seating should be a consideration. A "task" chair with adjustable positioning for the seat, back and armrests can facilitate better body mechanics.

Graphic courtesy of Herman Miller

At Contract Design, customers can even take one of 50 available task chairs home for a "test sit," Marlow notes, adding it can be hard to assess a chair's features without trying it in your own space, with your own office set up.

Also, Marlow says it's a good idea to consider an adjustable-height desk, so you can alternate between sitting and standing. After all, when it comes to sitting, too much is not a good thing. "Those who sat for more than eight hours a day with no physical activity had a risk of dying similar to the risks of dying posed by obesity and smoking," according to the Mayo Clinic.

Taking frequent breaks is also good for your eyes, which can suffer from too much screen time. Be smart about glare, Marlow says, and sit next to natural light if possible.

"I think the light makes us feel better," she says.

Continued here:

Remote Possibilities: The evolution of the home office - Pacific Northwest Inlander

How Did the First Person Evolve? – Gizmodo Australia

We know humans havent always been around. After all, we wouldnt have survived alongside meat-eating dinosaurs like Tyrannosaurus rex.

How the first person came about and who their ancestors were (their grandparents, great-grandparents and so on) is one of the biggest questions archaeologists have. Even today, it puzzles us.

When we think of how humans first came about, we have to first understand that almost every living thing evolved from something else through the process of evolution.

For instance, the first known example of life on Earth dates back more than 3.5 billion years.

This early life would have been in the form of tiny microbes (too small to see with just our eyes) that lived underwater in a very different world to today. At that time, the continents were still forming and there was no oxygen in the air.

Since then, life on Earth has changed incredibly and taken many forms.

In fact, for about a billion years during the middle part of Earths history (1.8 billion to 800 million years ago), life on Earth was nothing more than a large layer of slime.

All living humans today belong to a species called Homo sapiens.

However, we have a long line of family members called hominins who came before us including our ancient human relative, the Neanderthal (Homo neanderthalensis).

Homo sapiens are the only hominin alive today.

These two sculptures are imaginings of what a neanderthal man and woman may have looked like. Neanderthals are extinct today but were also hominins. Martin Meissner/AP

Hominins first showed up millions of years ago, and changed in mostly small ways over a long time, through evolution.

Because of this complicated family tree, in answering your question we need to think about what you mean by person.

This may seem silly, because we know straight away when we pass someone on the street that theyre a person, rather than a dog or cat.

However, the differences between you and your early ancestor Lucy (more about her below) who lived more than 100,000 generations ago, are much smaller than the differences between a person and a dog. This is why the answer is complicated.

So Im going to give you two answers and let you decide which you think is right.

The first answer is to assume the first person was the first member of our species, Homo sapiens. This person would have been just like you and me, but without an iPhone!

The oldest skeleton discovered of our species Homo sapiens (so far) is from Morocco and is about 300,000 years old.

This ancestor of ours would have lived at the same time as other members of the human family, including Neanderthals and Denisovans. Archaeologists have long argued about what makes us different to these other ancient types of humans.

The answer probably lies in our brains. We think Homo sapiens are the only species that can do things like create art and language although some recent discoveries suggest Neanderthals were artists too.

Its hard to know why Homo sapiens survived and the rest of our hominin family didnt. But theres a good chance the creativity that led to some wonderful early cave paintings found in France and Indonesia helped us to succeed over the last 100,000 years.

Another way to answer your question is by assuming the first person was the first hominin to split off from the rest of our extended family, which includes chimpanzees and gorillas.

We cant be sure exactly who our first ancestor was, but many scientists think Australopithecus afarensis is a good bet.

This species would have looked different to you and me, but still would have walked upright and used tools made of stone. The best example of this is a famous fossil skeleton called Lucy.

What Lucy may have looked like when she was alive more than three million years ago. Jason Kuffer/Flickr, CC BY-NC-ND

Her skeleton was found in Africa, and while we have a lot of it compared to other ancient hominin skeletons, its not complete. This makes it hard to work out who the first person was.When Lucy was alive about 3.18 million years ago she was covered in hair. And she was probably about the same height as you are now, even though her bones tell us she was an adult when she died.

Most fossils from Lucys time are incomplete, and we only have a handful of bones to study from each extinct species.

This is why every new discovery in archaeology is so exciting. Each new fossil gives us a new chance to put the puzzle of our family tree together.

Ian Moffat, ARC DECRA Senior Research Fellow in Archaeological Science, Flinders University

This article is republished from The Conversation under a Creative Commons license. Read the original article.

View original post here:

How Did the First Person Evolve? - Gizmodo Australia

Lake Wales (FL) Officials Can’t Handle an Atheist Invocation on the Agenda – Friendly Atheist – Patheos

Back in May, Sarah Ray, the co-founder and director of the Atheist Community of Polk County (in Florida), gave an invocation in front of the Board of Commissioners that urged officials to make decisions which root our policymaking process in these values that are relevant to all Polk County residents.

Very sensible advice. Not controversial at all.

This Tuesday, Ray is schedule to give a speech at a meeting of the Lake Wales City Commission. Her presence at the meeting is already creating a stir among the commissioners, according to the Lake Wales News.

Its not because of what she plans to say; its because of what she might say.

Who will she be praying to? asked Commissioner Al Goldstein, who said he plans to set his Bible on the dais and exit the room when Ray speaks.

Commissioner Curtis Gibson said he likely will join the meeting online but may turn his back on Ray, noting I dont just let anyone pray over me.

Goldsteins question is ignorant because it doesnt matter what the answer is. Both men have the right to act like petty children by putting a Bible on the dais or turning his back on her, but its telling that theyre only doing this because the speaker isnt Christian. They fully expect speakers to worship their God, oblivious to how non-Christians feel every time we have to hear Jesus believers pray at these meetings.

And make no mistake, Christians are typically the only people who give invocations:

The Lake Wales City Commission in the past has restricted its invocations to city chaplain Dr. James Moyer, or in his absence, the mayor or a commissioner. Moyer did the invocation in 24 of the last 38 meetings.

We always have our Christian chaplain give invocations! If not him, then one of the Christian commissioners! Why would anyone have a problem with this?!

He answered his own question.

One official even said he would speak with the citys attorney about this.

Interim City Manager James Slaton said he would be talking more about the issue to City Attorney Chuck Galloway, but that it appears that a recent federal appeals court ruling against the Brevard County Commission may give the city no choice.

Slaton wants to speak to a lawyer who will eventually tell him Rays invocation is perfectly legal. Whats especially troubling about that whole exchange, though, is that it may provide cover for the whiny commissioners. It allows them to say We dont WANT an atheist to give an invocation, but the courts are MAKING us! Blame them!

Last night, I asked Ray what she thought about all this.

She told me she was originally planning to deliver the invocation over Zoom to lead by example but if these commissioners cant handle her presence, she may well show up in person. If nothing else, it gives her a chance to make eye contact with some of these people while also putting her group front and center. Its also a better way to build relationships with city leaders. (I dont think theres anything selfish about doing this for the sake of visibility. Thats part of why people volunteer to give invocations! To represent a group in front of city officials.)

As for the contents of her invocation, I wouldnt expect anything divisive. That wasnt the case before and thats not likely to change now. Its obvious that Rays words dont matter to these commissioners anyway; her atheism is more than enough to upset some of them.

(Thanks to Joseph for the link)

View post:

Lake Wales (FL) Officials Can't Handle an Atheist Invocation on the Agenda - Friendly Atheist - Patheos

Feds offer more protections to seals than humans – Boston Herald

Maines first shark-caused human fatality came as a shock to residents and vacationers alike, but the odds of that occurring in Massachusetts waters increase virtually daily, thanks to conservation efforts that have swelled both seal and shark populations.

Authorities have confirmed that a 63-year-old woman from New York City was killed by a great white shark on Monday while swimming with her daughter off Harpswell, Maines Bailey Island.

Julie Dimperio Holowach became the first known person to die from a shark attack in Maines history, Patrick Keliher, the states Marine Patrol Commissioner, said at a Tuesday press conference.

Holowach, wearing a wetsuit, was swimming with her daughter about 20 yards from the shore when she was attacked. Thankfully her daughter escaped injury.

A fragment of a shark tooth found in the area of the attack was later positively identified by a Massachusetts Division of Marine Fisheries official as belonging to a great white.

The only other confirmed shark attack in Maine occurred 10 years ago near Eastport.

Swimmers and boaters were urged to use caution near Bailey Island, and avoid swimming near schooling fish or seals.

Thats certainly easier to do along the Maine coast.

But off Cape Cod beaches? Not so much.

Years of federal protection efforts have caused a proliferation of grey and harbor seals on the Cape and South Shore, especially off the coast of Chatham.

And that in turn has attracted the sealsprimary predator, sharks, in mounting numbers.

Its actually amazing that since 2012, there have only been three shark attacks off Wellfleet and Truro, on the outer Cape. Two years ago, 26-year-old Arthur Medici was killed while boogie-boarding at Newcomb Hollow Beach in Wellfleet the first shark attack fatality in 82 years in Massachusetts.

While its difficult to assess how many sharks invade the Cape during the summer season, experts agree the seal population has reached staggering proportions.

Sharon Young, the marine issues field director for the Humane Society of the United States, told the Associated Press in a July 2019 interview that nearly 300,000 seals go back and forth between Canada and the U.S.

The Marine Mammal Protection Act allows states to assume the responsibility for conservation and management of a species once it reaches its optimum sustainable population.

However Young conceded that controlling Cape Cods seal population would be a daunting likely impossible task.

Thats because the 10,000 (seals) that are on a specific beach today are not the same 10,000 that might be there tomorrow.

Thats essentially the same answer aMassachusetts citizens group seeking ways to protect Cape Cod beachgoers from great white sharks received last year.

Peter Howell, a founder of the Seal Action Committee, wanted Congress to amend the federal Marine Mammal Protection Act so seals and other species can be removed from the laws list of protected animals if their populations have sufficiently rebounded.

Democratic Congressman Bill Keating, who represents Cape Cod, said at the time delisting seals from the protection act wouldnt change things. He reiterated Humane Society Field Director Youngs assertion that the migration of gray seals from Canada would quickly replace any vacuum.

So, beachgoers, seals and sharks are here to stay guests no less of the federal government which apparently values their welfare over its human constituentslives and limbs.

Read the original:

Feds offer more protections to seals than humans - Boston Herald

$2M to local roads through allocation fund – News – Bedford Now

By Elena Meadows Journal Correspondent

ThursdayAug6,2020at12:20PM

More than $2 million will be funneled to local roads through the St. Joseph County Road Commissions allocation fund.

In a collaboration between the road commission and 12 of the countys 16 townships, the road commission contributes 50 percent toward improvements such as chip-seal and hot-mix asphalt. Townships contribute the other 50 percent.

"That is how you improve your local road network," road commission managing director John Lindsey told road commissioners at their meeting Wednesday.

Township contributions toward the program range from $10,000 to $159,400, as budgets allow.

Among the townships not participating this year, Sturgis Township is saving for a bigger project in 2021 and Burr Oak Township canceled participation due to COVID-19.

Lindsey made special note of 1.49 miles of asphalt overlay work recently performed in Fennells subdivision of Fawn River Township. The road commission put in half, taxpayers paid for a large portion through a special assessment district and the township funded the remainder.

Also on Wednesday, road commissioners discussed graffiti that had been painted near the intersection of Pulver and Floating Bridge roads in Flowerfield Township. Commissioners directed staff members that, as time permits, they should paint over any writing on roads the county maintains.

View post:

$2M to local roads through allocation fund - News - Bedford Now

The Trailer For Hulu’s New Comedy Woke Is Like Sorry to Bother You in All the Best Ways – POPSUGAR

New Girl's Lamorne Morris stars in Hulu's upcoming comedy series Woke, and if you're still reeling over the ending of Sorry to Bother You, you might want to check it out ASAP. The series follows Keef (Morris), a cartoonist on the verge of success whose life gets turned upside down after police roughly detain him for a crime he didn't commit. Before the incident, Keef preferred to "keep it light" and ignore the thinly veiled racism all around him. But the misunderstanding leaves him rightfully shaken, and he sets out to incite some much-needed social and political change with the help of his cartoons come to life.

Keef's new outlook on the world following his encounter with the police causes him to hear voices and talk to inanimate objects that take on the appearance of characters from his cartoons. These voices encourage him to take action in response to the instances of police brutality and systemic racism that permeate his everyday life and challenge those around him to do the same. Inspired by the life of cartoonist Keith Knight, Woke confronts the struggles the Black community faces in America today and takes a look at the importance of identity and culture through a comedic lens.

Morris will star alongside T. Murph, Blake Anderson, and Saturday Night Live's Sasheer Zamata. Woke premieres on Hulu on Sept. 9. In the meantime, enjoy the full series trailer above!

Read more here:

The Trailer For Hulu's New Comedy Woke Is Like Sorry to Bother You in All the Best Ways - POPSUGAR

Impact of Covid-19 on Malignant Mesothelioma Market Market to Witness High Demand During 2020-2027 – Levee Report

An introduction to Malignant Mesothelioma Market Report

Marketo Graphics has released a new research report named as Malignant Mesothelioma Market 2020 to its extensive database. The report is inclusive of numerical data and certified data, which is gathered from certified sources and market experts. It includes and evaluates all the changes and shifts that are observed in the market and its supplementary markets. The provided information can, therefore, be used to improve and strengthen a firms standing in the Malignant Mesothelioma market.

This is the most recent report inclusive of the COVID-19 effects on the functioning of the market. It is well known that some changes, for the worse, were administered by the pandemic on all industries. The current scenario of the business sector and pandemics impact on the past and future of the industry are covered in this report.

This report focuses on top manufacturers in global market, with production, price, revenue and market share for each manufacturer, covering

AstraZeneca Plc., Bristol-Myers Squibb Company, F. Hoffmann-La Roche Ltd., Merck & Co., Inc., Novartis AG, Pfizer Inc., Sanofi, Eli Lilly and Company, Teva Pharmaceuticals, Boehringer Ingelheim GmbH, Mylan N.V., Fresenius Kabi AG, Sun Pharmaceuticals Industries Ltd, Corden Pharma International GmbH, Concordia International Corp, Kyowa Hakko Kirin Co Ltd., Polaris Pharmaceuticals, Inc., MolMed SpA, Ono Pharmaceutical Co. Ltd, Nichi-Iko Pharmaceutical Co., Ltd

Interested in this Malignant Mesothelioma market report? Get your FREE sample now! https://www.marketographics.com/sample-enquiry-form/11681

By Drug TypePemetrexed, Cisplatin, Carboplatin, Gemcitabine, Vinorelbine, Others

By AdministrationOral, Parenteral

By Distribution ChannelHospital Pharmacies, Retail Pharmacies, Oncology Centers

Estimating the potential size of the Malignant Mesothelioma industry

Industry experts conducting the study further estimate the potential of the Malignant Mesothelioma industry. Such information is important for firms looking to launch an innovative service or product on the market. Industry experts have measured the total volume of the given market. Researchers have calculated the industry in terms of sales by the competitors and end-user customers. Data on the entire size of the Malignant Mesothelioma market for a particular product or a service for the forecast period, 2019 to 2026 covered in the report makes it valuable. This information reveals the upper limit of the Malignant Mesothelioma industry for a specific product or service.

!!! Limited Time DISCOUNT Available!!! Get Your Copy at Discounted [emailprotected] https://www.marketographics.com/discount-enquiry-form/11681

Knowing the trends influencing the industry performance

Stakeholders, marketing executives and business owners planning to refer a market research report can use this study to design their offerings and understand how competitors attract their potential customers and manage their supply and distribution channels. When tracking the trends researchers have made a conscious effort to analyze and interpret the consumer behaviour. Besides, the research helps product owners to understand the changes in culture, target market as well as brands so they can draw the attention of the potential customers more effectively.

Geographically, this report studies the key regions, focuses on product sales, value, market share and growth opportunity in these regions, covering:

United States

Europe

China

Japan

Southeast Asia

India

Browse complete Malignant Mesothelioma report description And Full TOC @ https://www.marketographics.com/industry-reports/malignant-mesothelioma-market

There are many questions the research attempts to answer:

Why Choose Marketo Graphics?

Order Your Copy Now (Customized report delivered as per your specific requirement) @ https://www.marketographics.com/checkout-form11681

To summarize, the global Malignant Mesothelioma market report studies the contemporary market to forecast the growth prospects, challenges, opportunities, risks, threats, and the trends observed in the market that can either propel or curtail the growth rate of the industry. The market factors impacting the global sector also include provincial trade policies, international trade disputes, entry barriers, and other regulatory restrictions.

About Us:With reports from over 500 prominent publishers as well as daily updates on our collection, intended to empower companies and individuals catch-up with vital insights on industries operating across different geographies, along with the trends, share, size and growth rate of market verticals and numerous other services, we have our fingers dipped in just about everything market research-related. Besides meticulously curated research reports, our clients can also access our specialized services without any additional charges to gain vital market insights.

Contact Us:John WatsonHead of Business DevelopmentOffice No, 203 Chandan Nagar,Kharadi Pune, Maharashtra 411014Direct Line:+918484002482Visit our News Site:http://newssucceed.com

David is an Experience Business writer who regularly contributes to the blog, He specializes in manufacturing news

Originally posted here:

Impact of Covid-19 on Malignant Mesothelioma Market Market to Witness High Demand During 2020-2027 - Levee Report

Impact of Covid-19 on Malignant Mesothelioma Market to Witness High Demand During 2020-2027 – Research Newspaper

An introduction to Malignant Mesothelioma Market Report

Marketo Graphics has released a new research report named as Malignant Mesothelioma Market 2020 to its extensive database. The report is inclusive of numerical data and certified data, which is gathered from certified sources and market experts. It includes and evaluates all the changes and shifts that are observed in the market and its supplementary markets. The provided information can, therefore, be used to improve and strengthen a firms standing in the Malignant Mesothelioma market.

This is the most recent report inclusive of the COVID-19 effects on the functioning of the market. It is well known that some changes, for the worse, were administered by the pandemic on all industries. The current scenario of the business sector and pandemics impact on the past and future of the industry are covered in this report.

This report focuses on top manufacturers in global market, with production, price, revenue and market share for each manufacturer, covering

AstraZeneca Plc., Bristol-Myers Squibb Company, F. Hoffmann-La Roche Ltd., Merck & Co., Inc., Novartis AG, Pfizer Inc., Sanofi, Eli Lilly and Company, Teva Pharmaceuticals, Boehringer Ingelheim GmbH, Mylan N.V., Fresenius Kabi AG, Sun Pharmaceuticals Industries Ltd, Corden Pharma International GmbH, Concordia International Corp, Kyowa Hakko Kirin Co Ltd., Polaris Pharmaceuticals, Inc., MolMed SpA, Ono Pharmaceutical Co. Ltd, Nichi-Iko Pharmaceutical Co., Ltd

Interested in this Malignant Mesothelioma market report? Get your FREE sample now! https://www.marketographics.com/sample-enquiry-form/11681

By Drug TypePemetrexed, Cisplatin, Carboplatin, Gemcitabine, Vinorelbine, Others

By AdministrationOral, Parenteral

By Distribution ChannelHospital Pharmacies, Retail Pharmacies, Oncology Centers

Estimating the potential size of the Malignant Mesothelioma industry

Industry experts conducting the study further estimate the potential of the Malignant Mesothelioma industry. Such information is important for firms looking to launch an innovative service or product on the market. Industry experts have measured the total volume of the given market. Researchers have calculated the industry in terms of sales by the competitors and end-user customers. Data on the entire size of the Malignant Mesothelioma market for a particular product or a service for the forecast period, 2019 to 2026 covered in the report makes it valuable. This information reveals the upper limit of the Malignant Mesothelioma industry for a specific product or service.

!!! Limited Time DISCOUNT Available!!! Get Your Copy at Discounted [emailprotected] https://www.marketographics.com/discount-enquiry-form/11681

Knowing the trends influencing the industry performance

Stakeholders, marketing executives and business owners planning to refer a market research report can use this study to design their offerings and understand how competitors attract their potential customers and manage their supply and distribution channels. When tracking the trends researchers have made a conscious effort to analyze and interpret the consumer behaviour. Besides, the research helps product owners to understand the changes in culture, target market as well as brands so they can draw the attention of the potential customers more effectively.

Geographically, this report studies the key regions, focuses on product sales, value, market share and growth opportunity in these regions, covering:

United States

Europe

China

Japan

Southeast Asia

India

Browse complete Malignant Mesothelioma report description And Full TOC @ https://www.marketographics.com/industry-reports/malignant-mesothelioma-market

There are many questions the research attempts to answer:

Why Choose Marketo Graphics?

Order Your Copy Now (Customized report delivered as per your specific requirement) @ https://www.marketographics.com/checkout-form11681

To summarize, the global Malignant Mesothelioma market report studies the contemporary market to forecast the growth prospects, challenges, opportunities, risks, threats, and the trends observed in the market that can either propel or curtail the growth rate of the industry. The market factors impacting the global sector also include provincial trade policies, international trade disputes, entry barriers, and other regulatory restrictions.

About Us:With reports from over 500 prominent publishers as well as daily updates on our collection, intended to empower companies and individuals catch-up with vital insights on industries operating across different geographies, along with the trends, share, size and growth rate of market verticals and numerous other services, we have our fingers dipped in just about everything market research-related. Besides meticulously curated research reports, our clients can also access our specialized services without any additional charges to gain vital market insights.

Contact Us:John WatsonHead of Business DevelopmentOffice No, 203 Chandan Nagar,Kharadi Pune, Maharashtra 411014Direct Line:+918484002482Visit our News Site:http://newssucceed.com

Original post:

Impact of Covid-19 on Malignant Mesothelioma Market to Witness High Demand During 2020-2027 - Research Newspaper

Greater Bay | Shenzhen emerges as engine of Chinas tech frontier – Macau Daily Times

In the northern suburbs of tech city Shenzhen, a forest of tower cranes stand at the site of a cow farm that is being transformed into a scientific engine.Here, the Guangming Science City is taking shape. The cluster of scientific facilities and universities now lies at the heart of Chinas ambition to build the Guangdong-Hong Kong-Macau Greater Bay Area into a science and innovation center.According to the local government, the Guangming Science City has launched construction of 60 projects, involving total investments of 140 billion yuan (20 billion U.S. dollars).The Shenzhen Bay Laboratory, which focuses on biomedical research, is among the latest to settle in the tech park in June. So far, the lab has assembled 49 teams to carry out COVID-19 research, including on virus sequencing and antibodies, said Zhan Qimin, director of the lab.Labs and basic science facilities are also prospering in other parts of Guangdong Province, helping the manufacturing heartland in south China rise as a new destination for the countrys, even the worlds, researchers.In 2018, the China Spallation Neutron Source opened in Dongguan as a super microscope to observe the microstructure of matter. A neutrino observatory is under construction in Jiangmen City, and a high-intensity heavy-ion accelerator is being built in Huizhou City.China has been promoting joint development in the bay area, which comprises Hong Kong, Macau and nine cities in Guangdong. Last year, China issued a more specific development plan for the area. One of its major aims is to build an international innovation and technology hub.Zhong Hai, an official in charge of Shenzhens technological sector, said the construction of basic science installations will improve the overall innovation capacity of Shenzhen, which is better known for housing Chinas many tech firms like Huawei and Tencent.The construction of the innovation hub has already lured in many graduates from Hong Kong, according to Xinhua, which neighbors Shenzhen and boasts many universities.Sing Chan, who launched an e-commerce platform in Shenzhen, is busy assisting Hong Kong entrepreneurs who wish to set up their businesses on the Chinese mainland.Over half of the Hong Kong teams came to the mainland for software and engineering hardware projects, according to the young entrepreneur from Hong Kong, who has helped bring over 200 Hong Kong-invested companies and entrepreneurial teams into Shenzhen.Peter Ding, who founded a high-tech firm on robotic applications in Shenzhen, noted the bay areas manufacturing prowess, which can help high-tech firms efficiently realize their brainchild.They (tech firms) can rely on Shenzhen as a research and development center, assemble products in cities like Foshan and Dongguan and benefit from basic science research in Hong Kongs universities, Ding said. MDT/Xinhua

More here:

Greater Bay | Shenzhen emerges as engine of Chinas tech frontier - Macau Daily Times

Nanotechnology Textile Market Projected to Witness Vigorous Expansion by 2020-2026 | Nano Textile, Colmar, eSpin Technologies – Market Research Posts

QY Research has Published Latest Trending Report on Global Nanotechnology Textile Market

Los Angeles, United State, The report titledGlobal Nanotechnology Textile Industry Research Report, Growth Trends and Competitive Analysis 2020-2026is one of the most comprehensive and important additions to QY Researchs archive of market research studies. It offers detailed research and analysis of key aspects of the global Nanotechnology Textile market. The market analysts authoring this report have provided in-depth information on leading growth drivers, restraints, challenges, trends, and opportunities to offer a complete analysis of the global Nanotechnology Textile market. Market participants can use the analysis on market dynamics to plan effective growth strategies and prepare for future challenges beforehand. Each trend of the global Nanotechnology Textile market is carefully analyzed and researched about by the market analysts.

Request Sample Report and Full Report TOC:https://www.qyresearch.com/sample-form/form/2039838/global-nanotechnology-textile-industry

The Essential Content Covered in the GlobalNanotechnology Textile Market Report:

* Top Key Company Profiles.* Main Business and Rival Information* SWOT Analysis and PESTEL Analysis* Production, Sales, Revenue, Price and Gross Margin* Market Share and Size

Global Nanotechnology Textile Market is estimated to reach xxx million USD in 2020 and projected to grow at the CAGR of xx% during 2020-2026. According to the latest report added to the online repository of QY Research the Nanotechnology Textile market has witnessed an unprecedented growth till 2020. The extrapolated future growth is expected to continue at higher rates by 2025.

Top Players of Nanotechnology Textile Market are Studied: , Nano Textile, Colmar, eSpin Technologies, FTEnE, Parker Hannifin, Schoeller Textil, Odegon Technologies, Shanghai Huzheng Nano Technology, Aspen Aerogel

The report provides a 6-year forecast (2020-2026) assessed based on how the Nanotechnology Textile market is predicted to grow in major regions likeUSA, Europe, Japan, China, India, Southeast Asia, South America, South Africa, Others.

Segmentation by Type:, Nanocoated Textiles, Nanoporous Textiles, Fabrics Consisting of Nanofiber Webs, Composite Fibers Based on Nanostructures

Segmentation by Application:, Healthcare, Packaging, Sports and Leisure, Defense, Others

Reasons to Buy this Report:

Table of Contents

1 Report Overview1.1 Research Scope1.2 Top Nanotechnology Textile Manufacturers Covered: Ranking by Revenue1.3 Market Segment by Type1.3.1 Global Nanotechnology Textile Market Size by Type: 2015 VS 2020 VS 2026 (US$ Million)1.3.2 Nanocoated Textiles1.3.3 Nanoporous Textiles1.3.4 Fabrics Consisting of Nanofiber Webs1.3.5 Composite Fibers Based on Nanostructures1.4 Market Segment by Application1.4.1 Global Nanotechnology Textile Consumption by Application: 2015 VS 2020 VS 20261.4.2 Healthcare1.4.3 Packaging1.4.4 Sports and Leisure1.4.5 Defense1.4.6 Others1.5 Study Objectives1.6 Years Considered 2 Global Market Perspective2.1 Global Nanotechnology Textile Revenue (2015-2026)2.1.1 Global Nanotechnology Textile Revenue (2015-2026)2.1.2 Global Nanotechnology Textile Sales (2015-2026)2.2 Global Nanotechnology Textile Market Size across Key Geographies Worldwide: 2015 VS 2020 VS 20262.2.1 Global Nanotechnology Textile Sales by Regions (2015-2020)2.2.2 Global Nanotechnology Textile Revenue by Regions (2015-2020)2.3 Global Top Nanotechnology Textile Regions (Countries) Ranking by Market Size2.4 Nanotechnology Textile Industry Trends2.4.1 Nanotechnology Textile Market Trends2.4.2 Nanotechnology Textile Market Drivers2.4.3 Nanotechnology Textile Market Challenges2.4.4 Nanotechnology Textile Market Restraints2.4.5 Primary Interviews with Key Nanotechnology Textile Players: Views for Future 3 Competitive Landscape by Manufacturers3.1 Global Top Nanotechnology Textile Manufacturers by Sales (2015-2020)3.1.1 Global Nanotechnology Textile Sales by Manufacturers (2015-2020)3.1.2 Global Nanotechnology Textile Sales Market Share by Manufacturers (2015-2020)3.1.3 Global 5 and 10 Largest Manufacturers by Nanotechnology Textile Sales in 20193.2 Global Top Manufacturers Nanotechnology Textile by Revenue3.2.1 Global Nanotechnology Textile Revenue by Manufacturers (2015-2020)3.2.2 Global Nanotechnology Textile Revenue Share by Manufacturers (2015-2020)3.2.3 Global Nanotechnology Textile Market Concentration Ratio (CR5 and HHI)3.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Nanotechnology Textile as of 2019)3.4 Global Nanotechnology Textile Average Selling Price (ASP) by Manufacturers3.5 Key Manufacturers Nanotechnology Textile Plants/Factories Distribution and Area Served3.6 Date of Key Manufacturers Enter into Nanotechnology Textile Market3.7 Key Manufacturers Nanotechnology Textile Product Offered 3.8 Mergers & Acquisitions, Expansion Plans 4 Market Size by Type4.1 Global Nanotechnology Textile Historic Market Review by Type (2015-2020)4.1.2 Global Nanotechnology Textile Sales Market Share by Type (2015-2020)4.1.3 Global Nanotechnology Textile Revenue Market Share by Type (2015-2020)4.1.4 Nanotechnology Textile Price by Type (2015-2020)4.1 Global Nanotechnology Textile Market Estimates and Forecasts by Type (2021-2026)4.2.2 Global Nanotechnology Textile Sales Forecast by Type (2021-2026)4.2.3 Global Nanotechnology Textile Revenue Forecast by Type (2021-2026)4.2.4 Nanotechnology Textile Price Forecast by Type (2021-2026) 5 Global Nanotechnology Textile Market Size by Application5.1 Global Nanotechnology Textile Historic Market Review by Application (2015-2020)5.1.2 Global Nanotechnology Textile Sales Market Share by Application (2015-2020)5.1.3 Global Nanotechnology Textile Revenue Market Share by Application (2015-2020)5.1.4 Nanotechnology Textile Price by Application (2015-2020)5.2 Global Nanotechnology Textile Market Estimates and Forecasts by Application (2021-2026)5.2.2 Global Nanotechnology Textile Sales Forecast by Application (2021-2026)5.2.3 Global Nanotechnology Textile Revenue Forecast by Application (2021-2026)5.2.4 Nanotechnology Textile Price Forecast by Application (2021-2026) 6 North America6.1 North America Nanotechnology Textile Breakdown Data by Company6.2 North America Nanotechnology Textile Breakdown Data by Type6.3 North America Nanotechnology Textile Breakdown Data by Application6.4 North America Nanotechnology Textile Breakdown Data by Countries6.4.1 North America Nanotechnology Textile Sales by Countries6.4.2 North America Nanotechnology Textile Revenue by Countries6.4.3 U.S.6.4.4 Canada 7 Europe7.1 Europe Nanotechnology Textile Breakdown Data by Company7.2 Europe Nanotechnology Textile Breakdown Data by Type7.3 Europe Nanotechnology Textile Breakdown Data by Application7.4 Europe Nanotechnology Textile Breakdown Data by Countries7.4.1 Europe Nanotechnology Textile Sales by Countries7.4.2 Europe Nanotechnology Textile Revenue by Countries7.4.3 Germany7.4.4 France7.4.5 U.K.7.4.6 Italy7.4.7 Russia 8 Asia Pacific8.1 Asia Pacific Nanotechnology Textile Breakdown Data by Company8.2 Asia Pacific Nanotechnology Textile Breakdown Data by Type8.3 Asia Pacific Nanotechnology Textile Breakdown Data by Application8.4 Asia Pacific Nanotechnology Textile Breakdown Data by Regions8.4.1 Asia Pacific Nanotechnology Textile Sales by Regions8.4.2 Asia Pacific Nanotechnology Textile Revenue by Regions8.4.3 China8.4.4 Japan8.4.5 South Korea8.4.6 India8.4.7 Australia8.4.8 Taiwan8.4.9 Indonesia8.4.10 Thailand8.4.11 Malaysia8.4.12 Philippines8.4.13 Vietnam 9 Latin America9.1 Latin America Nanotechnology Textile Breakdown Data by Company9.2 Latin America Nanotechnology Textile Breakdown Data by Type9.3 Latin America Nanotechnology Textile Breakdown Data by Application9.4 Latin America Nanotechnology Textile Breakdown Data by Countries9.4.1 Latin America Nanotechnology Textile Sales by Countries9.4.2 Latin America Nanotechnology Textile Revenue by Countries9.4.3 Mexico9.4.4 Brazil9.4.5 Argentina 10 Middle East and Africa10.1 Middle East and Africa Nanotechnology Textile Breakdown Data by Type10.2 Middle East and Africa Nanotechnology Textile Breakdown Data by Application10.3 Middle East and Africa Nanotechnology Textile Breakdown Data by Countries10.3.1 Middle East and Africa Nanotechnology Textile Sales by Countries10.3.2 Middle East and Africa Nanotechnology Textile Revenue by Countries10.3.3 Turkey10.3.4 Saudi Arabia10.3.5 U.A.E 11 Company Profiles11.1 Nano Textile11.1.1 Nano Textile Corporation Information11.1.2 Nano Textile Business Overview11.1.3 Nano Textile Nanotechnology Textile Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)11.1.4 Nano Textile Nanotechnology Textile Products and Services11.1.5 Nano Textile SWOT Analysis11.1.6 Nano Textile Recent Developments11.2 Colmar11.2.1 Colmar Corporation Information11.2.2 Colmar Business Overview11.2.3 Colmar Nanotechnology Textile Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)11.2.4 Colmar Nanotechnology Textile Products and Services11.2.5 Colmar SWOT Analysis11.2.6 Colmar Recent Developments11.3 eSpin Technologies11.3.1 eSpin Technologies Corporation Information11.3.2 eSpin Technologies Business Overview11.3.3 eSpin Technologies Nanotechnology Textile Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)11.3.4 eSpin Technologies Nanotechnology Textile Products and Services11.3.5 eSpin Technologies SWOT Analysis11.3.6 eSpin Technologies Recent Developments11.4 FTEnE11.4.1 FTEnE Corporation Information11.4.2 FTEnE Business Overview11.4.3 FTEnE Nanotechnology Textile Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)11.4.4 FTEnE Nanotechnology Textile Products and Services11.4.5 FTEnE SWOT Analysis11.4.6 FTEnE Recent Developments11.5 Parker Hannifin11.5.1 Parker Hannifin Corporation Information11.5.2 Parker Hannifin Business Overview11.5.3 Parker Hannifin Nanotechnology Textile Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)11.5.4 Parker Hannifin Nanotechnology Textile Products and Services11.5.5 Parker Hannifin SWOT Analysis11.5.6 Parker Hannifin Recent Developments11.6 Schoeller Textil11.6.1 Schoeller Textil Corporation Information11.6.2 Schoeller Textil Business Overview11.6.3 Schoeller Textil Nanotechnology Textile Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)11.6.4 Schoeller Textil Nanotechnology Textile Products and Services11.6.5 Schoeller Textil SWOT Analysis11.6.6 Schoeller Textil Recent Developments11.7 Odegon Technologies11.7.1 Odegon Technologies Corporation Information11.7.2 Odegon Technologies Business Overview11.7.3 Odegon Technologies Nanotechnology Textile Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)11.7.4 Odegon Technologies Nanotechnology Textile Products and Services11.7.5 Odegon Technologies SWOT Analysis11.7.6 Odegon Technologies Recent Developments11.8 Shanghai Huzheng Nano Technology11.8.1 Shanghai Huzheng Nano Technology Corporation Information11.8.2 Shanghai Huzheng Nano Technology Business Overview11.8.3 Shanghai Huzheng Nano Technology Nanotechnology Textile Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)11.8.4 Shanghai Huzheng Nano Technology Nanotechnology Textile Products and Services11.8.5 Shanghai Huzheng Nano Technology SWOT Analysis11.8.6 Shanghai Huzheng Nano Technology Recent Developments11.9 Aspen Aerogel11.9.1 Aspen Aerogel Corporation Information11.9.2 Aspen Aerogel Business Overview11.9.3 Aspen Aerogel Nanotechnology Textile Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)11.9.4 Aspen Aerogel Nanotechnology Textile Products and Services11.9.5 Aspen Aerogel SWOT Analysis11.9.6 Aspen Aerogel Recent Developments 12 Value Chain and Sales Channels Analysis12.1 Nanotechnology Textile Value Chain Analysis12.2 Sales Channels Analysis12.2.1 Nanotechnology Textile Sales Channels12.2.2 Nanotechnology Textile Distributors12.3 Nanotechnology Textile Customers 13 Estimates and Projections by Regions (2021-2026)13.1 Global Nanotechnology Textile Sales Forecast (2021-2026)13.1.1 Global Nanotechnology Textile Sales Forecast by Regions (2021-2026)13.1.2 Global Nanotechnology Textile Revenue Forecast by Regions (2021-2026) 13.2 North America Market Size Forecast (2021-2026)13.2.1 North America Nanotechnology Textile Sales Forecast (2021-2026)13.2.2 North America Nanotechnology Textile Revenue Forecast (2021-2026)13.2.3 North America Nanotechnology Textile Size Forecast by County (2021-2026) 13.3 Europe Market Size Forecast (2021-2026)13.3.1 Europe Nanotechnology Textile Sales Forecast (2021-2026)13.3.2 Europe Nanotechnology Textile Revenue Forecast (2021-2026)13.3.3 Europe Nanotechnology Textile Size Forecast by County (2021-2026) 13.4 Asia Pacific Market Size Forecast (2021-2026)13.4.1 Asia Pacific Nanotechnology Textile Sales Forecast (2021-2026)13.4.2 Asia Pacific Nanotechnology Textile Revenue Forecast (2021-2026)13.4.3 Asia Pacific Nanotechnology Textile Size Forecast by Region (2021-2026) 13.5 Latin America Market Size Forecast (2021-2026)13.5.1 Latin America Nanotechnology Textile Sales Forecast (2021-2026)13.5.2 Latin America Nanotechnology Textile Revenue Forecast (2021-2026)13.5.3 Latin America Nanotechnology Textile Size Forecast by County (2021-2026) 13.6 Middle East and Africa Market Forecast13.6.1 Middle East and Africa Nanotechnology Textile Sales Forecast (2021-2026)13.6.2 Middle East and Africa Nanotechnology Textile Revenue Forecast (2021-2026)13.6.3 Middle East and Africa Nanotechnology Textile Size Forecast by County (2021-2026) 14 Research Findings and Conclusion 15 Appendix15.1 Research Methodology15.1.1 Methodology/Research Approach15.1.2 Data Source15.2 Author Details15.3 Disclaimer

About US

QY Research is a leading global market research and consulting company. Established in 2007 in Beijing, China, QY Research focuses on management consulting, database and seminar services, IPO consulting, industry chain research and custom research to help our clients in providing non-linear revenue model and make them successful. We are globally recognized for our expansive portfolio of services.

Read this article:

Nanotechnology Textile Market Projected to Witness Vigorous Expansion by 2020-2026 | Nano Textile, Colmar, eSpin Technologies - Market Research Posts

Aerospace Nanotechnology Market Current Trends, Swot Analysis, Business Overview and Forecast by 2028 | Key Players: Airbus, Glonatech, Flight Shield,…

A recent report published by QMI on the aerospace nanotechnology market is a detailed assessment of the most important market dynamics. After carrying out a thorough research of aerospace nanotechnology market historical as well as current growth parameters, business expectations for growth are obtained with utmost precision.

Get Sample Copy of This Report @https://www.quincemarketinsights.com/request-sample-62977?utm_source=PF/SG

The study identifies specific and important factors affecting the market for aerospace nanotechnology during the forecast period. It can enable companies investing in aerospace nanotechnology market to change their production and marketing strategies in order to envisage maximum growth.

According to the report, the aerospace nanotechnology market has been segmented by product type (nanomaterials, nanotools, nanodevices), by end user (aircraft parts, fuselage structure, aero engine parts, aircraft electronic communication system, other).

Insights about regional distribution of market:The market has been segmented in major regions to understand the global development and demand patterns of this market. For aerospace nanotechnology market, the segments by region are North America, Asia Pacific, Western Europe, Eastern Europe, Middle East, and Rest of the World. During the forecast period, North America, Asia Pacific and Western Europe are expected to be major regions on the aerospace nanotechnology market.

North America and Western Europe have been dominant players in this market with the presence of major companies which have a strong infrastructure to boost aerospace &defense sector. In addition, some of the major countries like the US, France, UK, and Canada has been global exporters of aerospace &defense technologies due to established research & development centers, and others. Also, some of the major companies operating in aerospace nanotechnology market are headquartered in these regions.

The Asia Pacific region is estimated to register fastest growing aerospace nanotechnology market since some of the major economies like China, India, and South Korea are present in the region. In recent decades, these countries have witnessed strong government spending on defense infrastructure, as well as promoting air transport and space research. During the forecast period, the Middle East region is estimated to be a potential region for aerospace nanotechnology market in the aerospace and defense sector. It is estimated that Eastern Europe will have stable demand during the forecast period. Also, the rest of the world is expected to be an emerging market with increasing demand.

Company profiled in this report based on Business overview, Financial data, Product landscape, Strategic outlook & SWOT analysis:

1. Airbus2. Glonatech3. Flight Shield4. Lockheed Martin5. Lufthansa Technik, tripleO Performance Solution6. Zyvex Technologies7. CHOOSE NanoTech8. General Nano9. HR TOUGHGUARD10. Metamaterial Technologies.

Make an Inquiry for purchasing this Report @https://www.quincemarketinsights.com/enquiry-before-buying/enquiry-before-buying-62977?utm_source=PF/SG

Market Segmentation:By Product Type:o Nanomaterialso Nanotoolso Nanodevices

By End User:o Aircraft Partso Fuselage Structureo Aero Engine Partso Aircraft Electronic Communication Systemo Other

By Region:North Americao North America, by Countryo USo Canadao Mexicoo North America, by Product Typeo North America, by End User

Western Europeo Western Europe, by Countryo Germanyo UKo Franceo Italyo Spaino The Netherlandso Rest of Western Europeo Western Europe, by Product Typeo Western Europe, by End User

Asia Pacifico Asia Pacific, by Countryo Chinao Indiao Japano South Koreao Australiao Indonesiao Rest of Asia Pacifico Asia Pacific, by Product Typeo Asia Pacific, by End User

Eastern Europeo Eastern Europe, by Countryo Russiao Turkeyo Rest of Eastern Europeo Eastern Europe, by Product Typeo Eastern Europe, by End User

Middle Easto Middle East, by Countryo UAEo Saudi Arabiao Qataro Irano Rest of Middle Easto Middle East, by Product Typeo Middle East, by End User

Rest of the Worldo Rest of the World, by Countryo South Americao Africao Rest of the World, Product Typeo Rest of the World, by End User

Objectives of this report:o To estimate the market size for the aerospace nanotechnology market on a regional and global basis.o To identify major segments in the aerospace nanotechnology market and evaluate their market shares and demand.

o To provide a competitive scenario for the aerospace nanotechnology market with major developments observed by key companies in the historic years.o To evaluate key factors governing the dynamics of the aerospace nanotechnology market and their potential gravity during the forecast period.

Reasons to Buy This Report:o Offers unique insights into the decision-making process for every possible segment that aids in strategic decision making.o Market size estimate of regionally and internationally focused aerospace nanotechnology market.o Unique research methodology based on the dynamics of the aerospace nanotechnology market.o Identification of major companies operating in the industry with key strategies adopted in recent yearso Exhaustive scope to help each stakeholder across the value chain of the aerospace nanotechnology market.

Customization:This study is customized to meet your specific requirements:o By Segmento By Sub-segmento By Region/Countryo Product Specific Competitive Analysis

Contact:

Quince Market InsightsAjay D. (Knowledge Partner)Office No- A109Pune, Maharashtra 411028Phone: APAC +91 706 672 4848 / US +1 208 405 2835 / UK +44 144 439 0986Email:[emailprotected]Web:www.quincemarketinsights.com

ABOUT US:

QMI has the most comprehensive collection of market research products and services available on the web. We deliver reports from virtually all major publications and refresh our list regularly to provide you with immediate online access to the worlds most extensive and up-to-date archive of professional insights into global markets, companies, goods, and patterns.

Read the original post:

Aerospace Nanotechnology Market Current Trends, Swot Analysis, Business Overview and Forecast by 2028 | Key Players: Airbus, Glonatech, Flight Shield,...

How studying genetics and lifestyle can shape a healthier MENA region – The European Sting

(Credit: Unsplash)

This article is brought to you thanks to the collaboration ofThe European Stingwith theWorld Economic Forum.

Author: Habiba Al Alsafar, Associate Professor, Department of Biomedical Engineering, Khalifa University of Science, Technology and Research (KUSTAR) & Elizabeth ODay, Founder and Chief Executive Officer, Olaris Inc

Diagnosing diseases can be complex, because illness is not a fixed state and has to be considered in context. We may be born with factors that predispose us to disease, but our lifestyle dictates if and when undesirable symptoms will manifest themselves.

For example, our middle-eastern forefathers were relatively healthier than us because of a nomadic lifestyle which was considerably more active. Our genes have remained unchanged in our recent history, yet the prevalence of a number of lifestyle diseases such as diabetes and obesity has risen in contemporary middle eastern countries. This is in part due to a shift towards more sedentary lifestyles. The environment and our lifestyles are working in concert with inherent elements (that is, the products of our genome) to contribute to the status of our health.

The intersection of genetics and lifestyle choices is playing an increasingly significant role in managing the health of middle eastern populations. The prevalence of chronic disease, in particular diabetes and its associated complications, is alarmingly high throughout the Gulf States. According to the 2017 report from the International Diabetes Federation, 11% of the population in the Middle East and North Africa (MENA) region has diabetes. Disturbingly, the prevalence is higher in the population of countries like the United Arab Emirates (UAE), where 19.3% of those between the ages of 20 and 79 have type-2 diabetes. A number of major co-morbidities are linked to diabetes and of these, cardiovascular disease is the highest cause of mortality in the UAE, accounting for 40% of mortalities. Non-communicable diseases (NCDs) in total are responsible for 77% of all deaths in the UAE. Both men and women are dying prematurely, resulting in a profound impact on families specifically and the community on the whole. The impact is not only limiting progress and development of the nation, it has a bearing on government spending as treating end-stage disease carries significant costs.

To manage the health of a nation we must shift our attention to examine both genetics and the impact of lifestyle choices.

A recent audit of the worlds genomic data showed that the predominant genomes in public databases belong to Europeans (81%), while only 0.08% of the genome inventory represents ancestries from Arab and Middle Eastern populations. The genomes of people of Asian and African ancestries at 14% and 3% respectively were also relatively low.

A breakdown of non-European genomic data samples

Image: Nature

As alluded to above, the genome is a key part of the puzzle that is required for understanding disease within a population. Efforts are clearly being made to increase our understanding of the genomes of people with middle eastern ancestries and the genomes from efforts in Kuwait, Qatar and the UAE are now available. It comes at a time when sequencing costs have plummeted and are no longer prohibitive. Innovation in genome sequencing technologies does not appear to be slowing, and continued reductions in the cost can be expected.

We have and continue to propose the need to develop collaborative linkages: locally, throughout the region and internationally. Collaboration needs to be encouraged and should involve all sectors of healthcare, including practicing physicians and paramedics, policy-makers and research scientists. It is only through coordinated efforts throughout the region that patients will ultimately be provided with the information that will enable individuals, and their care providers, to make informed decisions about their health and wellbeing. Importantly, strong local leadership is required, because as the Portuguese writer and Nobel laureate Jos Saramago put it: If you dont write your books, nobody else will do it for you. No one else has lived your life.

NCDs account for 77% of all deaths in UAE

Image: WHO

The paradigm shift in healthcare that personalized or precision medicine customizing medical treatment to the individual characteristics, needs and preferences of a patient during all stages of care represents has been made possible through the availability of large datasets compiled by healthcare systems, technological advancements in next-generation genome sequencing and the development of proper analytical tools to identify relationships in vast datasets.

This is a systems biology approach that uses genome, phenome and microbiome data to quantify the wellness of an individual and to provide indicators of their impending disease state. The Pioneer 100 Wellness Project (P100) was a longitudinal study in the US designed to test this approach. It that was conceived on the rationale that as the scale of personal data increases with the convergence of advances in electronic health records sets, big data analysis, individual measurement devices, and consumer-activated social networks, it would be possible to define early warning signs for human diseases. Although the opportunities for observing health transitions in P100 were limited, the results were sufficiently compelling that it has justified refinements for an extended study involving a larger population of more than 100,000 individuals.

Health and healthcareHow is the World Economic Forum bringing data-driven healthcare to life?

The application of precision medicine to save and improve lives relies on good-quality, easily-accessible data on everything from our DNA to lifestyle and environmental factors. The opposite to a one-size-fits-all healthcare system, it has vast, untapped potential to transform the treatment and prediction of rare diseasesand disease in general.

But there is no global governance framework for such data and no common data portal. This is a problem that contributes to the premature deaths of hundreds of millions of rare-disease patients worldwide.

The World Economic Forums Breaking Barriers to Health Data Governance initiative is focused on creating, testing and growing a framework to support effective and responsible access across borders to sensitive health data for the treatment and diagnosis of rare diseases.

The data will be shared via a federated data system: a decentralized approach that allows different institutions to access each others data without that data ever leaving the organization it originated from. This is done via an application programming interface and strikes a balance between simply pooling data (posing security concerns) and limiting access completely.

The project is a collaboration between entities in the UK (Genomics England), Australia (Australian Genomics Health Alliance), Canada (Genomics4RD), and the US (Intermountain Healthcare).

Although currently viewed as a radical shift, preemptive measures have been proposed since the turn of the last century. In 1903, motivated by concerns about the healthcare of his time, Thomas Edison said: The doctor of the future will give no medicine, but will interest his patient in the care of the human frame, in diet and in the cause and prevention of disease. Through the more than 100 years since this statement, preventative strategies have taken hold in some areas of medicine (such as immunization), but there is more to do. In the words of the 11th century Persian physician and polymath Avicenna, There are no incurable diseases only the lack of will. There are no worthless herbs only the lack of knowledge. There is certainly no lack of will, and our knowledge is only expanding.

Therefore, the opportunity to apply personal medicine practices in the UAE to prevent or delay the onset of disease will have substantial social and economic impacts. The American physcian and systems biologist Dr Leroy Hood has predicted that the wellness and prevention market will outgrow the healthcare market, in part due to economic modelling which suggests that the reactive therapeutic route is unsustainable for ageing populations. The time to act is now.

Read the original:

How studying genetics and lifestyle can shape a healthier MENA region - The European Sting

Immatics Extends Cell Therapy Manufacturing Collaboration with UTHealth – marketscreener.com

Houston, Texas, Aug. 06, 2020 (GLOBE NEWSWIRE) --

Houston, Texas, August 6, 2020 Immatics N.V. (NASDAQ: IMTX; Immatics), a clinical-stage biopharmaceutical company active in the discovery and development of T cell redirecting cancer immunotherapies, today announced the extension of its cell therapy manufacturing collaboration with The University of Texas Health Science Center at Houston (UTHealth), in Houston, Texas. The continued collaboration grants Immatics access to UTHealths state-of-the-art cGMP manufacturing infrastructure at the Evelyn H. Griffin Stem Cell Therapeutics Research Laboratory, enabling continued production and supply of Immatics specialized, cell-based product candidates for testing in multiple clinical trials. Maximum capacity of the facility is anticipated at 48 ACTengine T cell products per month. The new agreement will run until the end of 2024. Under the agreement, UTHealth will provide Immatics with exclusive access to three cGMP suites and support areas for the manufacturing of various Adoptive Cell Therapy (ACT) products. Therapeutic T cell production will be carried out by Immatics manufacturing personnel and will be supported by a UTHealth-Immatics joint quality team.

Steffen Walter, Ph.D., Chief Technology Officer at Immatics, commented: During the last five years, we have established a strong and productive partnership with UTHealth that has enabled the initiation of four ongoing clinical trials. As we remain focused on the development of our clinical pipeline, this extension of our collaboration with UTHealth will fulfill Immatics manufacturing needs for our early-stage ACT clinical programs for the next four years. Being able to rely on a partner with profound cell therapy expertise who is familiar with our technologies and can support cGMP cell therapy production is critical to ensuring the advancement of our clinical trials. We look forward to continuing this fruitful collaboration with the experts at UTHealth.

Fabio Triolo, D.d.R., M.Phil., Ph.D., The Clare A. Glassell Distinguished Chair and Director of the Cellular Therapy Core at UTHealth, added: Signing the extended contract with Immatics fits into our strategy at UTHealth of supporting the development of new treatments for patients in need. We therefore look forward to continuing our collaboration and further leveraging the potential of our manufacturing capabilities.

About Immatics ACT ProgramsACTengine is a personalized approach in which the patients own T cells are genetically modified to express a novel proprietary TCR cognate to one of Immatics proprietary cancer targets which are then reinfused back into the patient. Immatics latest proprietary ACTengine manufacturing processes are designed to generate cell product candidates within a short six day manufacturing window and to deliver highly proliferative T cells, with the capability to infiltrate the patients tumor and function in a challenging solid tumor microenvironment. The process is designed to rapidly produce younger, better-persisting T cells capable of serial killing tumor cells in vitro. Immatics is further advancing the ACT concept beyond individualized manufacturing with its product class ACTallo which is being developed to generate off-the-shelf cellular therapies.

More information on the clinical trials can be found at the following links: https://immatics.com/clinical-programs/ and https://clinicaltrials.gov/.

- ENDS -Notes to Editors

About ImmaticsImmatics combines the discovery of true targets for cancer immunotherapies with the development of the right T cell receptors with the goal of enabling a robust and specific T cell response against these targets. This deep know-how is the foundation for our pipeline of Adoptive Cell Therapies and TCR Bispecifics as well as our partnerships with global leaders in the pharmaceutical industry. We are committed to delivering the power of T cells and to unlocking new avenues for patients in their fight against cancer.

For regular updates about Immatics, visit http://www.immatics.com. You can also follow us on Twitter and LinkedIn.

About UTHealthEstablished in 1972 by The University of Texas System Board of Regents, The University of Texas Health Science Center at Houston (UTHealth) is Houstons Health University and Texas resource for health care education, innovation, scientific discovery and excellence in patient care. The most comprehensive academic health center in the UT System and the U.S. Gulf Coast region, UTHealth is home to Jane and Robert Cizik School of Nursing, John P. and Kathrine G. McGovern Medical School and schools of biomedical informatics, biomedical sciences, dentistry and public health. UTHealth includes The University of Texas Harris County Psychiatric Center, as well as the growing clinical practices UT Physicians, UT Dentists and UT Health Services. The universitys primary teaching hospitals are Memorial Hermann-Texas Medical Center, Childrens Memorial Hermann Hospital and Harris Health Lyndon B. Johnson Hospital. For more information, visit http://www.uth.edu.

About the Evelyn H. Griffin Stem Cell Therapeutics Research LaboratoryThe Evelyn H. Griffin Stem Cell Therapeutics Research Laboratory, which is part of the Cellular Therapy Core at UTHealth, has been Immatics manufacturing partner since 2015. The site is a U.S. Food and Drug Administration (FDA)-registered and inspected cGMP facility that has received accreditation from the Foundation for Accreditation of Cellular Therapy (FACT) as well as certification from the Clinical Laboratory Improvement Amendment (CLIA) and the College of American Pathologists (CAP).

Forward-Looking StatementsCertain statements in this press release may be considered forward-looking statements. Forward-looking statements generally relate to future events or Immatics future financial or operating performance. For example, statements concerning the timing of product candidates and Immatics focus on partnerships to advance its strategy are forward-looking statements. In some cases, you can identify forward-looking statements by terminology such as may, should, expect, intend, will, estimate, anticipate, believe, predict, potential or continue, or the negatives of these terms or variations of them or similar terminology. Such forward-looking statements are subject to risks, uncertainties, and other factors which could cause actual results to differ materially from those expressed or implied by such forward looking statements. These forward-looking statements are based upon estimates and assumptions that, while considered reasonable by Immatics and its management, are inherently uncertain. New risks and uncertainties may emerge from time to time, and it is not possible to predict all risks and uncertainties. Factors that may cause actual results to differ materially from current expectations include, but are not limited to, various factors beyond management's control including general economic conditions and other risks, uncertainties and factors set forth in filings with the Securities and Exchange Commission (SEC). Nothing in this presentation should be regarded as a representation by any person that the forward-looking statements set forth herein will be achieved or that any of the contemplated results of such forward-looking statements will be achieved. You should not place undue reliance on forward-looking statements, which speak only as of the date they are made. Immatics undertakes no duty to update these forward-looking statements.

Go here to read the rest:

Immatics Extends Cell Therapy Manufacturing Collaboration with UTHealth - marketscreener.com

New Report: Regenerative Medicine & Advanced Therapies Sector Thriving Despite COVID-19 – GlobeNewswire

Cell, Gene & Tissue-Based Therapy Developers Poised to Break Year-Over-Year Global Financing Records

WASHINGTON, D.C., Aug. 06, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE --The Alliance for Regenerative Medicine (ARM), the leading international advocacy organization dedicated to realizing the promise of regenerative medicines and advanced therapies, today announces the publication of its H1 2020 Global Sector Report, Innovation in the Time of COVID-19. The report provides an in-depth look at trends and metrics in the gene, cell, and tissue-based therapeutic sector in the midst of the pandemic.

As the voice of the sector globally, ARM regularly publishes sector data reports to showcase clinical and scientific progress, as well as advancements and remaining challenges in the policy environment surrounding cell, gene and tissue-based therapies. The report also includes updated metrics on fundraising and clinical trials from more than 1,000 therapeutic developers worldwide.

Highlights from the H1 2020 Global Sector Report include:

Janet Lambert, CEO of ARM, commented:The regenerative medicine and advanced therapy sector has shown remarkable resilience in the face of many new challenges posed by COVID-19. Most importantly, were continuing to see patients benefit from the profound therapeutic effects of both approved products and those currently in clinical development. ARM will continue to work with our membership and with policymakers in the second half of 2020 to further advance these transformative technologies. We are committed to bringing these life-changing therapies to patients in need.

This report is the latest in ARMs series of global regenerative medicine sector reports, providing up-to-date metrics on financings and the clinical landscape, as well as expert commentary on key trends and progress in the field. The full report is availableonline here, with key sector metrics and infographicsavailable here. For more information, please visitwww.alliancerm.orgor contact Kaitlyn (Donaldson) Dupont atkdonaldson@alliancerm.org.

About the Alliance for Regenerative Medicine

The Alliance for Regenerative Medicine (ARM) is the leading international advocacy organization dedicated to realizing the promise of regenerative medicines and advanced therapies. ARM promotes legislative, regulatory and reimbursement initiatives to advance this innovative and transformative sector, which includes cell therapies, gene therapies and tissue-based therapies. Early products to market have demonstrated profound, durable and potentially curative benefits that are already helping thousands of patients worldwide, many of whom have no other viable treatment options. Hundreds of additional product candidates contribute to a robust pipeline of potentially life-changing regenerative medicines and advanced therapies. In its 11-year history, ARM has become the voice of the sector, representing the interests of 360+ members worldwide, including small and large companies, academic research institutions, major medical centers and patient groups. To learn more about ARM or to become a member, visithttp://www.alliancerm.org.

Read more from the original source:

New Report: Regenerative Medicine & Advanced Therapies Sector Thriving Despite COVID-19 - GlobeNewswire

Impact of COVID-19 Outbreak on Canine Stem Cell Therapy Market Expected to Secure Notable Revenue Share During 2020-2026 – Research Newspaper

This Canine Stem Cell Therapy Market report includes worldwide topmost prime manufactures like (VETSTEM BIOPHARMA, Cell Therapy Sciences, Regeneus, Aratana Therapeutics, Medivet Biologics, Okyanos, Vetbiologics, VetMatrix, Magellan Stem Cells, ANIMAL CELL THERAPIES, Stemcellvet) in terms of company basic information, Product Category, Sales (Volume), Revenue (Million USD), Price, Gross Margin (%), Price, Cost, Growth Rate, Import, Export, Market Share and Technological Developments. Canine Stem Cell Therapy Market report provide the COVID19 Outbreak Impact analysis of key factors influencing the growth of the Canine Stem Cell Therapy market Size (Production, Value and Consumption). In the end, the Canine Stem Cell Therapy industry report introduced new project SWOT analysis, investment feasibility analysis, and investment return analysis.

Get Free Sample PDF (including COVID19 Impact Analysis, full TOC, Tables and Figures)of Canine Stem Cell Therapy[emailprotected]https://www.researchmoz.us/enquiry.php?type=S&repid=2081893

Canine Stem Cell Therapy Market Report Offers Comprehensive Assessment Of 1) Executive Summary, 2) Canine Stem Cell Therapy Market Overview, 3) Key Market Trends, 4) Key Success Factors, 5) Market Demand/Consumption (Value or Size in US$ Mn) Analysis, 6) Canine Stem Cell Therapy Market Background, 7) Canine Stem Cell Therapy industry Analysis & Forecast 20202026 by Type, Application and Region, 8) Canine Stem Cell Therapy Market Structure Analysis, 9) Competition Landscape, 10) Company Share and Company Profiles, 11) Assumptions and Acronyms and, 12) Research Methodology etc.

Scope of Canine Stem Cell Therapy Market:The non-invasive stem cell obtaining procedure, augmented possibility of accomplishing high quality cells, and lower price of therapy coupled with high success rate of positive outcomes have collectively made allogeneic stem cell therapy a preference for veterinary physicians. Moreover, allogeneic stem cell therapy is 100% safe, which further supports its demand on a global level. Pet owners are identified to prefer allogeneic stem cell therapy over autologous therapy, attributed to its relatively lower costs and comparative ease of the entire procedure.

A rapidly multiplying geriatric population; increasing prevalence of chronic ailments such as cancer and cardiac disease; growing awareness among patients; and heavy investments in clinical innovation are just some of the factors that are impacting the performance of the global healthcare industry.

On the basis on the end users/applications,this report focuses on the status and outlook for major applications/end users, shipments, revenue (Million USD), price, and market share and growth rate foreach application.

Veterinary Hospitals Veterinary Clinics Veterinary Research Institutes

On the basis of product type, this report displays the shipments, revenue (Million USD), price, and market share and growth rate of each type.

Allogeneic Stem Cells Autologous Stem cells

Do You Have Any Query Or Specific Requirement? Ask to Our Industry[emailprotected]https://www.researchmoz.us/enquiry.php?type=E&repid=2081893

The report offers in-depth assessment of the growth and other aspects of the Canine Stem Cell Therapy market in important countries (regions), including:

The Following Points Are Important In Performing A Competitive Assessment of Canine Stem Cell Therapy Market:

What will make the customer buy from this operation instead of the competition?

Comparison between the products/services to the competitors products/services of Canine Stem Cell Therapy market (Features, Service, Quality, Price, Distribution, And Brand).

List the companies involved in the production of these products/services.

Describe the Canine Stem Cell Therapy market concentration (Such As Large Number of Small Players or Small Number of Large Players).

Detail the Canine Stem Cell Therapy market prevailing competitive intensity (Fierce Competition or Live and Let-Live).

Describe the competitors facile Canine Stem Cell Therapy market entry (Can the Easy Entry of Competitors Drive down Prices in the Market?)

Describe the clients competitive strategies against competitors and their products of Canine Stem Cell Therapy market(Low Cost, Niche Market, Product Differentiation, Etc.).

Contact:

ResearchMozMr. Rohit Bhisey,Tel: +1-518-621-2074USA-Canada Toll Free: 866-997-4948Email:[emailprotected]

Browse More Reports Visit @https://www.mytradeinsight.blogspot.com/

Continued here:

Impact of COVID-19 Outbreak on Canine Stem Cell Therapy Market Expected to Secure Notable Revenue Share During 2020-2026 - Research Newspaper

UK housing is on the agenda. How do we really build back better? – Big Issue

In part one of a special investigation, we consider the government's move to make it easier for developers to create not-fit-for-purpose homes in office buildings

Britain is at a housing tipping point. Our need for social housing, built well and built quickly, has never been more urgent. There is less housing stock available, there is a need to find homes for the previously homeless to meet the laudable ambition currently sounded by the authorities, and there is a growing need for affordable new homes for many others. Quality and a good place to live are key.

However, last month Westminster housing secretary Robert Jenrick announced a change in legislation making it easier for developers to convert buildings like offices into residential units, a practice largely shown to produce shoddy homes that promote overcrowding. The government says this will help us build back from the Covid-19 crisis. It leaves the situation on the horns of a dilemma. Build quickly for now, or build correctly for tomorrow?

The extension of permitted development rights (PDR) means offices, shops and warehouses in England can now not only be repurposed for housing but also demolished entirely to build homes on the land without planning permission. It means developers can sidestep minimum space standards and arent beholden to Section 106 a requirement that they contribute to the local community, whether by creating a percentage of affordable housing or injecting cash into local amenities. Instead, they submit a prior approval notice to the local authority, who can only consider limited factors such as flood risk and traffic when deciding if the project can go ahead.

The idea is that the creation of something built to fit the national standards is streamlined. But the resulting homes are tiny flats as small as 13 square metres in some cases with poor ventilation and internal windows reducing privacy. Some have no windows at all.

New rules dont take into account what we have learned about housing from the Covid-19 crisis

When the Royal Institution of Chartered Surveyors (RICS) researched the issue in 2018, it concluded that these conversions come at a cost both financially and socially. At the time one resident in a Croydon office-to-residential conversion said that their building wasnt maintained and that the large number of children living there had no access to outdoor space where they could play. Another said that because the building wasnt built with residential use in mind, there was next to no noise insulation, impacting quality of life for those living inside.

Im speechless, one resident said. How can this be allowed in a civilised country? Its so wrong. The politicians who allowed this need to come and live here. Its a total nightmare.

Just 30 per cent of the homes created through extended PDR in the past met minimum space standards nearly 80 per cent were studios or one-bed units, compared to just 37 per cent of those created using the full planning permission process.

When compared to similar developments in Glasgow conversions in Scotland and Wales must still go down the planning route homes in the Scottish city were found to be much higher quality and better maintained, and had more space for families to live in. RICS concluded that easing up office-to-residential rules was a fiscal giveaway from the state to private real estate developers.

In fact, the PDR changes contradict the governments own research. The same week Jenrick made the announcement, the Ministry of Housing, Communities and Local Government published a report blasting office-to-residential conversions created without full planning permission as seeming to create worse quality residential environments than planning permission conversions in relation to matters of health, wellbeing and quality of life.

Its a policy that appears to produce a lot of housing quickly, says RICS associate director of planning and development Tony Mulhall, but housing with question marks all over it.

What I have seen when visiting conversions like these has shocked me, he says. People are expected to live without any natural light or space to move around.

Its no good having developers approach national standards as technicalities to comply to. Those standards are about function. Homes need to work for the people living in them or they shouldnt be built.

The idea of converting office buildings to homes is something that fits in with how our towns and cities are changing, he says and its likely office space will be less in demand in the future now that companies have discovered home working to be viable. We dont always have one area for offices, another for houses like we once did. And offices are often in really handy locations. If you can live close to where you work and shop close to where you live, that makes good sense. But those buildings are often just totally unsuitable to be converted.

Its an issue developers can exploit particularly in global cities like London, he adds, where many people are desperate for homes just to get a toehold in the area. The new rules dont take into account what we have learned about housing from the Covid-19 crisis that overcrowding is a danger to public health, and that outdoor space is vital. Instead of loosening restrictions, we should be thinking about how important the addition of a balcony can be to small flats, Mulhall says. And even when done well, these conversions dont turn out cheap.

Who are these homes going to be for? Thats something that should be asked more often, he says. Many of these units go into the private rental market, sometimes earmarked as affordable housing but in practice theyre very expensive. Research into office-to-residential conversions in Leeds and Leicester found they were mostly marketed as expensive student flats, doing little to meet local housing need. And last year it emerged that some of the 210,000 children whose families were caught up in the housingcrisis were moved into unsuitable converted office blocks as temporary accommodation.

New homes created through extended PDR have an impact on cash-strapped councils, too. RICS estimated that the financial impact to Englands local authorities was a net loss of around 50m. Around 42.5m of that came from the affordable housing contributions developers would have been required to make had they gone through the planning permission process. Councils are actively opposing the governments latest changes.

Councillor David Renard, housing spokesperson for the Local Government Association, tells The Big Issue: The planning system is not a barrier to housebuilding, with nine in 10 planning applications approved by councils. It gives local communities the power to shape the area they live in and provides an effective means of balancing the interests of homeowners and their neighbours.

Taking away the right of locals to have a say about what happens in their community deprives them of the ability to define the area they live in and know best, he says. It risks giving developers the freedom to ride roughshod over local areas with communities having no way of ensuring they meet high quality standards, provide any affordable homes as part of the development or ensure supporting infrastructure such as roads, schools and health services are in place.

RICS research also showed that PDR conversions made it more difficult for councils to meet local social housing need. Yet just days after Jenrick announced the changes for developers, a Westminster housing select committee released a report urging ministers to start building 90,000 social homes a year to beat Englands broken housing system.

Go here to see the original:

UK housing is on the agenda. How do we really build back better? - Big Issue

Calyxt will license its plant gene-editing tech to other firms – Minneapolis Star Tribune

Calyxt, a food technology company spawned by the University of Minnesota, said this week it will offer its gene-editing technology in licensing deals to other companies.

The company whose technology is known as TALEN and uses molecular scissors to remove undesirable traits in plants had until recently focused on contracting with farmers to grow their seeds and managing the manufacture of products made from the crops.

It is now in talks with several companies to license its technology or the specific traits in plants it has developed.

It would be a competitor to the CRISPR technology thats out there, but we believe we have a little cleaner commercialization plan with TALEN than what CRISPR has, said Travis Frey, the firms chief technology officer.

One high-profile example was high-oleic soybeans, which were converted into oil by a processor in Iowa and sold under the Calyxt brand Calyno.

In its new emphasis on licensing its technology and the traits it develops, Calyxt is pivoting away from managing the processing and sale of end products like oil, Frey said.

Most of the partners were looking at are probably going to put it under their own brand, Frey said. Theyre just much better at doing that, and the other thing is it helps us get revenue. We can earn cash sooner.

The publicly traded firm, launched in 2019, said it is in the advanced stages of developing improved-digestibility alfalfa, high fiber wheat, feminized and low THC hemp for fiber, food and CBD, gluten-free and cold-tolerant oats and pulses with improved flavor and protein.

Companies that want to develop products with that technology, or with traits developed by Calyxt, will now be able to secure a license.

Based in Roseville, the company got an exclusive license in 2015 to commercialize technology developed at the Us Department of Genetics, Cell Biology and Development.

Calyxt has not turned a profit since its inception and lost $39.6 million in 2019, but gene-editing is one of the hottest topics in agriculture.

Major seed companies are still working to dig out of the public relations and regulatory quagmire of genetically modified organisms, or GMOs. Gene-editing does not add foreign DNA to plants so the resulting products are not considered to be GMOs.

Follow this link:

Calyxt will license its plant gene-editing tech to other firms - Minneapolis Star Tribune

JinkoSolar reshapes PV technology scenarios with its new N-Type Tiger Pro 610W unveiled at SNEC 2020 – PRNewswire

SHANGRAO, China, Aug. 7, 2020 /PRNewswire/ -- JinkoSolar Holding Co., Ltd. ("JinkoSolar" or "Company") (NYSE: JKS) one of the world's largest and most innovative module manufacturers in the world, today launched its new generation of 610W Tiger Pro High-efficiency monocrystalline TR solar module and its BIPV solutions, Building Integrated Photovoltaics product series, which will be unveiled at SNEC 2020 in Shanghai.

As a PV company that has ranked first in global modules shipments for four consecutive years, JinkoSolar has always been committed to providing global customers with high-efficiency, top quality, and extremely reliable solar modules. The key behind the success of Tiger Pro 610W is the N-Type HOT 2.0 high-efficiency cell technology, independently developed by JinkoSolar. Thanks to the introduction of new technologies, such as HOT tunneling layer passivated contact and advanced metallization, the cell efficiency has reached 24.79%, setting once again a world record for the efficiency of large area N-Type monocrystalline silicon solar cells. At the same time, the use of 78 cell design and of TR technology, which helps reduce significantly the cell gap, as well as lower the electricity cost and improve the system compatibility, represents another milestone for the PV industry in its quest for grid parity.

JinkoSolar's module series have continuously broken the conversion efficiency record, starting from 2018, JinkoSolar Eagle PERC high-efficiency monocrystalline series, with a power of 390W and a conversion efficiency of 19.8%, followed by the Tiger HOT 1.0 high-efficiency monocrystalline series delivering a power output up to 475W and a conversion efficiency of 20.87%. The newest Tiger Pro HOT2.0, high-efficiency monocrystalline series, with its maximum output of 610W and a conversion efficiency of 22.3%, is setting once again new-standards for the industry and positioning JinkoSolar far ahead from its competitors.

Moreover, thanks to the great improvements made with the smart combination "PV + Architecture", during this edition of SNEC, JinkoSolar also unveiled its first version of colored BIPV module series.With a power output of up to 550W, this product series is available in a variety of colors and levels of translucence, incorporating modern architectural aesthetics for use as a building component.

Dr. Jin Hao, CTO of JinkoSolar, commented: "Reducing costs and increasing efficiency is the goal that the industry has always been striving for. JinkoSolar has always been committed to providing global customers with high-efficiency, top quality, and extremely reliable solar modules. We will increase our investment in R&D to ensure constant innovation in our technology, improve our products performance, and ensure the highest system compatibility. This will allow us to fulfill our commitment to offer the best service to our global customers and to allow the application of our solar modules in a variety of scenarios, further empowering the solar PV industry and achieving grid parity."

About JinkoSolar Holding Co., Ltd.

JinkoSolar (NYSE: JKS) is one of the largest and most innovative solar module manufacturers in the world. JinkoSolar distributes its solar products and sells its solutions and services to a diversified international utility, commercial and residential customer base in China, the United States, Japan, Germany, the United Kingdom, Chile, South Africa, India, Mexico, Brazil, the United Arab Emirates, Italy, Spain, France, Belgium, and other countries and regions. JinkoSolar has built a vertically integrated solar product value chain, with an integrated annual capacity of 17.5 GW for mono wafers, 10.6 GW for solar cells, and 16 GW for solar modules, as of March 31, 2020.

JinkoSolar has over 15,000 employees across its 7 productions facilities globally, 14 overseas subsidiaries in Japan, South Korea, Vietnam, India, Turkey, Germany, Italy, Switzerland, United States, Mexico, Brazil, Chile and Australia, and global sales teams in China, United Kingdom, France, Spain, Bulgaria, Greece, Ukraine, Jordan, Saudi Arabia, Tunisia, Morocco, Kenya, South Africa, Costa Rica, Colombia, Panama, Kazakhstan, Malaysia, Myanmar, Sri Lanka, Thailand, Vietnam, Poland and Argentina.

To find out more, please see: http://www.jinkosolar.com

Safe Harbor Statement

This press release contains forward-looking statements. These statements constitute "forward-looking" statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, and as defined in the U.S. Private Securities Litigation Reform Act of 1995. These forward-looking statements can be identified by terminology such as "will," "expects," "anticipates," "future," "intends, "plans," "believes," "estimates" and similar statements. Among other things, the quotations from management in this press release and the Company's operations and business outlook, contain forward-looking statements. Such statements involve certain risks and uncertainties that could cause actual results to differ materially from those in the forward-looking statements. Further information regarding these and other risks is included in JinkoSolar's filings with the U.S. Securities and Exchange Commission, including its annual report on Form 20-F. Except as required by law, the Company does not undertake any obligation to update any forward-looking statements, whether as a result of new information, future events or otherwise.

For investor and media inquiries, please contact:

Ms. Ripple ZhangJinkoSolar Holding Co., Ltd.Tel: +86 21-5183-3105Email: [emailprotected]

SOURCE JinkoSolar Holding Co., Ltd.

http://www.jinkosolar.com

See the original post here:

JinkoSolar reshapes PV technology scenarios with its new N-Type Tiger Pro 610W unveiled at SNEC 2020 - PRNewswire

By Next Year, Will Doctors Finally Have The Technology To Fully Personalize Treatments For Lung Cancer Patients? – Forbes

Today, with the new risks posed by Covid, how do we provide the best care for people with non-Covid- related disease? For diagnosed cancer patients, these risks may warrant a re-evaluation of the common standards of treatment.

While targeted cancer therapies are now more tumor-specific and less toxic, and offer new possibilities for tailoring cancer treatment, there are still so many missing pieces: often as not, oncologists are shooting in the dark, trying to tailor the right treatment for their patient with very limited data. With the shadow of Covid, and the multiple risks cancer patients now face, clinicians are increasingly concerned.

"There are very few good biomarkers that enable personalized treatment regimens and therefore, in ... [+] most cases, we have a one size fits all approach."

Today, we use protocols to treat our patients with lung or other kinds of cancers, says Dr. Ofer Sharon, a longtime physician and entrepreneur. There are very few good biomarkers that enable personalized treatment regimens and therefore, in most cases, we have a one size fits all approach. Treatment starts following diagnosis and staging and we start to follow up on patients using clinical capabilities. Then what he describes is rather disturbing. Doctors are left to speculate as to which degree patients are responding to treatment. Usually, response assessment happens after three and six months. During this period, there are a lot of uncertainties, and sometimes there are adverse events and associated costs. If the patient is not responding the way we had hoped, we lose valuable time. There is a consensus among clinicians, he notes, that not all patients are the same and theres a dire need for effective tools to differentiate between patients and personalize treatment according to their needs.

OncoHost, an Israeli precision oncology company is now in the final steps of finalizing a host response profiling platform for predicting patient response to cancer therapeutics.

With over 20 years of experience in clinical and commercial product development for startups in the health tech, biotech, and medical device industries, Dr. Sharon decided to join OncoHost, as its CEO, following a personal tragedy. Seven years ago my father-in-law was diagnosed with advanced-stage melanoma. At the time, I was the medical director for Merck (MSD) and involved in the phase 3 trials of Keytruda, a drug that treats melanoma. Unfortunately, my father-in-law didnt meet the inclusion criteria for the trial and passed away three months before we launched the new drug. The frustration, which arises from the fact that in most cases we just dont know in time which patients will benefit from treatment and which will not, kept me awake for many nights.

When he came across Oncohost, he realized there might be hope for others. I was fascinated by the concept and science. The opportunity to make such a crucial difference in the way we treat cancer was something I just couldnt pass up, and I decided to take on this huge challenge.

The companys technology is based on high-throughput protein analysis, machine-learning algorithms, and bioinformatics tools. Its product, PROphetTM, is currently under study in a multi-center international clinical trial to predict patient response to immune-checkpoint inhibitors for non-small cell lung cancer and melanoma.

"Potential combination strategies and alternative treatments that may mitigate treatment ... [+] resistance." Dr. Ofer Sharon

So far, it has successfully identified a 10-protein signature that distinguishes between responders and non-responders to anti-PD-1 monotherapy or anti-PD-1 and anti-CTLA-4 combination therapy for melanoma. The technology should elucidate protein patterns associated with resistance to immune checkpoint inhibitors and will fulfill the need for differentiating responders from non-responders while monitoring the immune checkpoint inhibitor specific protein expression scores such as tumor proportion score.

The system, now in the clinical trial stage, analyzes the patients response and provides the patient and physician with a response prediction. In cases where no response is predicted, it suggests potential combination strategies and alternative treatments that may mitigate treatment resistance. "We hope this platform will like a CT or MRI add much-needed clinical information to support the complex and in many cases, life-and-death decision-making process".

The technology for assessing response to lung cancer therapy is expected to become available in the U.S. by next year.

Read this article:

By Next Year, Will Doctors Finally Have The Technology To Fully Personalize Treatments For Lung Cancer Patients? - Forbes